A Case of Immune Aplastic Anemia during Combined Treatment with Atezolizumab and Chemotherapy for Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

A Case of Immune Aplastic Anemia during Combined Treatment with Atezolizumab and Chemotherapy for Non-Small Cell Lung Cancer

Published:2024-06-25 Issue:3 Volume:91 Page:339-346
ISSN:1345-4676
Container-title:Journal of Nippon Medical School
language:en
Short-container-title:J Nippon Med Sch

Author:

Matsuki Satoru¹,Taniuchi Namiko¹,Okada Naoko¹,Sato Junpei¹,Nishijima Nobuhiko¹,Kamio Koichiro¹,Motoda Norio²,Okamoto Muneo³,Seike Masahiro⁴,Azuma Arata¹

Affiliation:

1. Department of Pulmonary Medicine, Nippon Medical School Musashi Kosugi Hospital

2. Department of Diagnostic Pathology, Nippon Medical School Musashi Kosugi Hospital

3. Department of Hematology, Nippon Medical School

4. Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School

Publisher

Medical Association of Nippon Medical School

Link

https://www.jstage.jst.go.jp/article/jnms/91/3/91_JNMS.2024_91-302/_pdf

Reference20 articles.

1. 1. Sun C, Mezzadra R, Schumacher TN. Regulation and function of the PD-L1 checkpoint. Immunity. 2018;48 (3):434-52.

2. 2. Davis EJ, Salem JE, Young A, et al. Hematologic complications of immune checkpoint inhibitors. Oncologist. 2019;24 (5):584-8.

3. 3. Kramer R, Zaremba A, Moreira A, et al. Hematological immune related adverse events after treatment with immune checkpoint inhibitors. Eur J Cancer. 2021;147:170-81.

4. 4. Michot JM, Lazarovici J, Tieu A, et al. Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage? Eur J Cancer. 2019;122:72-90.

5. 5. Travis WD, Asamura H, Bankier AA, et al. The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol. 2016;11 (8):1204-23.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atezolizumab/ciclosporin/immune-globulin;Reactions Weekly;2024-08-03